Significant progress in cancer genomics and immunotherapy is accelerating the growth of the Neoantigens Market. Neoantigens are mutation-derived antigens found only in cancer cells, making them valuable targets for personalized treatment strategies. Increasing funding for immuno-oncology research, technological breakthroughs in genome sequencing, and the expanding use of precision medicine are...